Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
Biobeat has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Biobeat's investors include OrbiMed, Ally Bridge Group, Elevage Medical Technologies, Menomadin Foundation.
Biobeat is headquartered in Boca Raton, United States.
Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
Biobeat is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biobeat — Funding & Investors." VCBacked, December 30, 2025, https://www.vcbacked.co/company/biobeat. Accessed September 14, 2026.
VCBacked. (2025). Biobeat — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/biobeat
{{cite web |title=Biobeat — Funding & Investors |url=https://www.vcbacked.co/company/biobeat |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated